Sansum Diabetes Research Institute | Santa Barbara, CA

Research site

Location

2219 Bath Street, Santa Barbara, California, United States of America

Website

https://sansum.org/

Site insights

Top conditions

Top treatments

Tirzepatide

hydrocortisone

Acetaminophen

PRM-151

Zinpentraxin Alfa

LY3298176

Glucose

medroxyprogesterone

Estradiol

Baricitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

5 of 96 total trials

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults (BARICADE-DELAY)

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to devel...

Enrolling

Diabetes Mellitus, Type 1

Drug: Baricitinib

Drug: Placebo

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-1)

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight....

Active, not recruiting

Overweight

Type 1 Diabetes

Drug: Tirzepatide

Drug: Placebo

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System (STRIVE 2)

This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals...

Enrolling

Type 1 Diabetes Mellitus

Type 2 Diabetes Mellitus

Device: Omnipod 6 System

Device: Omnipod 5 System

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes (EVOLVE)

A multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults wit...

Enrolling

Type 2 Diabetes Mellitus

Device: Device: Omnipod M System with study CGM

Device: Standard Therapy plus study CGM

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes (INHALE-GDM)

Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study. We want to see how two different insulin treatments affect th...

Enrolling

Pregnancy Complications

Diabetes, Gestational

Drug: Inhaled Technosphere Insulin